ArticleHealth services research2005
Developing a quality measure for clinical inertia in diabetes care.
Article in Health services research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00012675 (Developing and Implementing a Quality Measure for Glycemic Control), which is not on this map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Developing and Implementing a Quality Measure for Glycemic Control
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.Diabetes, obesity & metabolism · 2018 · on this mapPooled it
- Trial
- Effects of a web-based patient activation intervention to overcome clinical inertia on blood pressure control: cluster randomized controlled trial.Journal of medical Internet research · 2013Trial
- A web-based patient activation intervention to improve hypertension care: study design and baseline characteristics in the web hypertension study.Contemporary clinical trials · 2010Trial
- Point-of-Care A1C and Time from Test to Communication of Results in Primary Care.Population health management · 2026Article
- A machine learning model to predict therapeutic inertia in type 2 diabetes using electronic health record data.Journal of endocrinological investigation · 2024Article
- Clinical inertia in newly diagnosed type 2 diabetes mellitus among patients attending selected healthcare institutions in Colombia.Diabetology & metabolic syndrome · 2024Article
- Intensifying approaches to address clinical inertia among cardiovascular disease risk factors: A narrative review.Patient education and counseling · 2022Review
- Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.Journal of managed care & specialty pharmacy · 2018Article
- Associations of Four Community Factors With Longitudinal Change in Hemoglobin ADiabetes care · 2018Article
- Article
- Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.Journal of general internal medicine · 2016Article
- Clinical inertia in general practice, a matter of debate: a qualitative study with 114 general practitioners in Belgium.BMC family practice · 2015Article
- Family physician clinical inertia in glycemic control among patients with type 2 diabetes.Medical science monitor : international medical journal of experimental and clinical research · 2015Observational
- Psychiatric disorders and pain treatment in community nursing homes.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2014Article
- Mobile Diabetes Intervention for Glycemic Control: Impact on Physician Prescribing.Journal of diabetes science and technology · 2014Article
- Quality indicators and performance measures in diabetes care.Current diabetes reports · 2014Review
- Factors associated with clinical inertia: an integrative review.Advances in medical education and practice · 2014Review
- Performance of primary care physicians and other providers on key process measures in the treatment of diabetes.Diabetes care · 2013Article
- Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device.ClinicoEconomics and outcomes research : CEOR · 2013Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a valid quality measure that captures clinical inertia, the failure to initiate or intensify therapy in response to medical need, in diabetes care and to link this process measure with outcomes of glycemic control. DATA SOURCES: Existing databases from 13 Department of Veterans Affairs hospitals between 1997 and 1999. STUDY
designLaboratory results, medications, and diagnoses were collected on 23,291 patients with diabetes. We modeled the decision to increase antiglycemic medications at individual visits. We then aggregated all visits for individual patients and calculated a treatment intensity score by comparing the observed number of increases to that expected based on our model. The association between treatment intensity and two measures of glycemic control, change in HbA1c during the observation period, and whether the outcome glycosylated hemoglobin (HbA1c) was greater than 8 percent, was then examined. PRINCIPAL
findingsIncreases in antiglycemic medications occurred at only 9.8 percent of visits despite 39 percent of patients having an initial HbA1c level greater than 8 percent. A clinically credible model predicting increase in therapy was developed with the principal predictor being a recent HbA1c greater than 8 percent. There were considerable differences in the intensity of therapy received by patients. Those patients receiving more intensive therapy had greater improvements in control (p < .001).
conclusionsClinical inertia can be measured in diabetes care and this process measure is linked to patient outcomes of glycemic control. This measure may be useful in efforts to improve clinicians management of patients with diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.